The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection.
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Hoffmann, SC; Kampen, RL; Pearl, JP; Hale, DA; Jacobson, LM; Kleiner, DE; Mannon, RB; Muehrer, RJ; Swanson, SJ; Becker, BN; Kirk, AD
Published Date
- January 1, 2004
Published In
Volume / Issue
- 4 /
Start / End Page
- 332 - 332
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 1600-6135
Conference Name
- American Transplant Congress
Conference Location
- Boston, MA
Conference Start Date
- May 14, 2004
Conference End Date
- May 19, 2004